Inequalities in heart attack care ‘costing women’s lives’

Women who suffer heart attacks are dying needlessly because they fail to recognise their symptoms and receive poorer care than men. says a British Heart Foundation report. Over 10 years, more than 8,000 women in England and Wales died unnecessarily after a heart attack, it found. Experts say there are inequalities in diagnosis, treatment and… Read More »

FDA Approves Rituxan (rituximab) for Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) in Children

Print this page South San Francisco, CA — September 27, 2019 — Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved Rituxan (rituximab), in combination with glucocorticoids, for the treatment of granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) in… Read More »

Medicaid may be the driver to reducing costs

Medicaid may be the best driver for healthcare cost reductions, according to Dr. Anita Cattrell, chief innovation officer for Evolent Health, which works with provider-led Medicaid plans to coordinate medical care with social resources for housing, food and behavioral health counseling. Cattrell co-developed Evolent’s Social Needs Index, which flags to physicians when aggregated data suggests… Read More »